The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The stock zoomed 52% to Rs 117 from Rs 77 after Insync Capital Partners LLP bought stake in Adlabs via open market
The stock rallied 12% to Rs 53.55 after the USFDA approval for loratadine liquid filed capsules 10 mg
The stock hit 52-week high of Rs 343, surging 55% in past three trading sessions from Rs 222 since September 21
Broader markets are outperforming- BSE Midcap and Smallcap indices are up 0.1%-0.2%
The stock listed at Rs 252, a 22% premium against issue price of Rs 207 per share, on the National Stock Exchange.
The stock hit a 52-week high of Rs 765, up 5.5% on the BSE in an early morning trade
The stock rallied 7% to Rs 1,108 after the board approved a buyback of 6.13 million equity shares for Rs 1,175 per share
The stock rallied 6% to Rs 266, trading near to its 52-week high of Rs 272 on the BSE.
The stock up 7% to Rs 868 after the company said that its QIP issue opened on Thursday, September 22, 2016.
Among broader markets, BSE Midcap and Smallcap indices are up 0.6% each
RIL, HDFC Bank, TVS Motor, Raymond, Biocon, Reliance Capital, Manappuram Finance and Bajaj Finserv hit 52-week highs.
A combined 6.54 million shares or 8% of total equity of Adlabs and there were pending buy orders for 1.07 million shares on both the exchanges at 11:51 am.
The stock up 20% at Rs 42.15 after the company said the RBI approved the restructuring of outstanding FCCBs subject to certain conditions.
Top losers from the Sensex pack are Axis Bank, Lupin, ICICI Bank, Tata Motors and Infosys
The Ondansetron Oral Spray has been launched in the dosage form of 0.2ml equivalent to 2mg and 0.4 ml equivalent to 4mg,
PTC India Financial, Satin Creditcare, Shriram Transport Fin, Bharat Financial, Muthoot Finance and M&M Financial were up 3%-6% on the BSE.
Index heavweight Reliance Industries was the top gainer along with financials
The stock hit 52-week high of Rs 80, appreciated 116% from Rs 37 on August 10, 2016.
The stock up 4% to Rs 842 after the company has received the tentative approval of Dolutegravir 50mg from USFDA for the treatment of HIV.
The stock locked in lower circuit of 5% at Rs 44.65 on the BSE.